Medtronic logo

Medtronic dividend TTMNYSE: MDT

Dividend per share (TTM)

$2.78
$0.000.00%

28 min ago

-19.19%vs 3 years high
+14.88%vs 3 years low
77.78%vs. sector
Performance
Most recent0.0%
1 year+1.5%
3 years+14.9%
5 years+33.6%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend per share (TTM) performance

Most recent change
MDT0.0%
GILD0.0%
BMY0.0%
SNY0.0%
1 year change
MDT+1.5%
GILD+2.7%
BMY+5.3%
SNY+7.2%
3 years change
MDT+14.9%
GILD+8.9%
BMY+22.4%
SNY+5.6%
5 years change
MDT+33.6%
GILD+24.4%
BMY+46.3%
SNY+17.1%

Dividend per share (TTM) performance

MDTGILDVRTXBSXBMYREGNSNY
today0.0%0.0%--0.0%-0.0%
1 month0.0%0.0%--+1.3%-0.0%
3 months+0.4%+0.7%--+1.3%-0.0%
6 months+0.7%+1.3%--+2.6%-+7.2%
ytd+1.1%+2.0%--+5.3%-+7.2%
1 year+1.5%+2.7%--+5.3%-+7.2%
3 years+14.9%+8.9%--+22.4%-+5.6%
5 years+33.6%+24.4%--+46.3%-+17.1%
FAQ

What is Medtronic dividend per share (ttm)?

Medtronic dividend per share (ttm) is $2.78

What is Medtronic dividend per share (ttm) compared to its 3-years maximum value?

Medtronic dividend per share (ttm) is 80.81% of its 3-years maximum value

What is Medtronic dividend per share (ttm) compared to other companies from its sector (Healthcare)?

Medtronic dividend per share (ttm) is higher than 77.78% of the companies in the same sector (Healthcare)

How has Medtronic dividend per share (ttm) changed over the year?

Over the past year, Medtronic dividend per share (ttm) has increased by 1.5%. During the same period, Gilead Sciences has increased by 2.7%, Bristol-Myers Squibb has increased by 5.3%, Sanofi has grown by 7.2%

How has Medtronic dividend per share (ttm) changed over the 3 years?

During the last 3 years, Medtronic dividend per share (ttm) has increased by 14.9%. Over the same period, Gilead Sciences has increased by 8.9%, Bristol-Myers Squibb has increased by 22.4%, Sanofi has grown by 5.6%

How has Medtronic dividend per share (ttm) changed over the 5 years?

For the past 5 years, Medtronic dividend per share (ttm) has increased by 33.6%. In the same period, Gilead Sciences has increased by 24.4%, Bristol-Myers Squibb has increased by 46.3%, Sanofi has grown by 17.1%